Navigation Links
Case Western Reserve receives $1.6M to study tumor cells and immune cell detection
Date:3/31/2011

Case Western Reserve University School of Medicine has received a $1.6 million grant from the National Cancer Institute (NCI) to study how tumor cells avoid detection by the body's immune system, allowing cancer to develop and spread.

The five-year National Institutes of Health grant will enable researchers led by Alex Y. Huang, MD, PhD, assistant professor of pediatrics, pathology, and biomedical engineering at the School of Medicine, and a hematologist and oncologist at Rainbow Babies & Children's Hospital at University Hospitals Case Medical Center, to examine "immune tolerance." The process keeps tumor cells from being detected by the immune system, even when they invade draining lymph nodes, a place where primary immune activation and surveillance take place. Lymph nodes are part of the body's lymphatic system, which fights off viruses, bacteria, and other disease-causing agents.

The study will also test whether modifying the environment in which tumor and immune cell interactions take place, using a group of proteins called inflammatory chemokines, will activate unresponsive immune cells into fighting off cancer. Using inflammatory chemokines as part of the anti-tumor strategies is a novel approach to cancer treatment.

"This research will provide greater insight into the potential therapeutic utilities of inflammatory chemokines, thereby providing a new direction for the development of immunotherapies that are capable of fighting cancer at the most basic cellular level," Dr. Huang says, who is also an associate member of the Case Comprehensive Cancer Center at the School of Medicine and director of the Pediatric Hematology-Oncology Fellowship Program at Rainbow Babies & Children's Hospital. "Any effective cellular immunotherapy must enhance long-term tumor immunity, effectively concentrating immune cells and priming them to destroy cancer cells anywhere in the body over long periods of time."

Researchers will work to leverage the immune system's unique ability to generate immune memory to eradicate any future cancer cell development that is derived from a primary tumor, according to Dr. Huang. They will use an advanced imaging technique called intravital 2-photon laser scanning microscopy to directly visualize tumor and immune cell interactions in real-time.

Dr. Huang's laboratory has been at the forefront of developing this imaging technology, which he says provides a "court-side" view of how tumors and the immune system interact with one another within intact tissue as cancer spreads to the lymph nodes. The technology is designed to provide a powerful in vivo experimental platform to monitor future anti-cancer or immunotherapy approaches, as opposed to static tissue analysis or single-cell analysis on a plastic petri dish, he explains.

Dr. Huang's research is among the first attempts to directly visualize the tolerance of immune cells by metastatic cancer cells in the draining lymph node at a cellar level, in a dynamic fashion.

As a practicing pediatric hematologist and oncologist, Dr. Huang aims to one day be able to apply the scientific insight gained from this research in a pediatric care setting.


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. UT Southwestern research advances fight against kidney cancer
2. Annual sonograms are needed to verify correct IUD position, UT Southwestern obstetricians say
3. Northwestern Medicine multiple sclerosis program earns national designation
4. UT Southwestern receives $36.7 million for cancer research
5. Foster parents receive more support than kinship caregivers, UT Southwestern study finds
6. UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
7. Homogeneous tuberculosis treatment ineffective in children, UT Southwestern researchers find
8. Western Diet May Raise Risk of Kidney Function Decline
9. Helping others helps alcoholics stay on the road to recovery, Case Western Reserve shows
10. Case Western Reserve receives $7.8M to study manic symptoms in children
11. Case Western Reserve and Athersys show regenerative benefit of MultiStem after spinal cord injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... OF PRUSSIA, PA and LONDON, UK (PRWEB) , ... May 06, ... ... to earn accolades for his success in changing the way the pharmaceutical industry conducts ... 100 list of the world’s most influential people in pharma, and he was honored ...
(Date:5/6/2016)... ... 06, 2016 , ... US Sports Camps has collaborated with State Rugby Organization ... University this summer. Employing world-class rugby figures, including former Team USA players and college ... on key fundamentals, match play, fitness and more. , “US Sports Camps is honored ...
(Date:5/6/2016)... ... May 06, 2016 , ... Innovations ... upcoming episode, airing third quarter 2016, via Discovery Channel. Dates and show times ... leader in optimized drug discovery through innovative cellular analysis. In this segment, viewers ...
(Date:5/6/2016)... ... May 06, 2016 , ... Online HR/benefits platforms offer a range ... game for traditional brokers and health plans. “ The Rapid Emergence of Online Benefits ... Atlantic Information Services, Inc. (AIS), will offer an accurate picture of online benefits today, ...
(Date:5/6/2016)... ... 06, 2016 , ... Canadian author Mark Black is a speaker, author, and life ... around the world … with the help of his publisher Strategic Book Group and its ... in a hospital bed waiting for a miracle: He needed a heart and double-lung transplant. ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 5, 2016 ... addition of the  "Europe Systemic Lupus Erythematosus ...  report to their offering.       ... The latest research Europe Systemic Lupus Erythematosus ... provides comprehensive insights into Systemic Lupus Erythematosus ...
(Date:5/4/2016)... COUNTY, Calif. , May 4, 2016  It,s time for an upgrade. There ... shown on a brilliant 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled ... brands as well as a world class manufacturer of innovative technology.  Photo ... ... ...
(Date:5/4/2016)... , May 4, 2016 ... Jerusalem announced today that it had signed an ... Inc. , developer of novel protein degradation and immunomodulatory ... and commercialization of drug candidates representing first-in-class therapy for ... were not disclosed. The novel technology was ...
Breaking Medicine Technology: